Restriction Enzymes, Bacteriophages & Nanotechnology — Detailed Study Notes

Restriction enzymes are a class of endonucleases whose substrate is DNA.
Endonuclease vs. DNase (Pulmozyme example):
- DNase cuts all DNA indiscriminately (non-specific cleavage).
- Restriction enzymes recognize short, specific sequences (restriction sites) and cut only there.
Fragment prediction example
- Linear DNA with $n$ restriction sites → $n+1$ fragments.
- Circular DNA with $n$ sites → $n$ fragments.
- Instructor’s question: “If one molecule of DNA has three restriction sites, how many fragments?” • Linear: $4$ • Circular: $3$ .
Purpose in bacteria: first line of microbial immune defense against foreign DNA (e.g., bacteriophage genomes).

Biology often understood by looking for patterns; evolutionary reasoning helps formulate hypotheses.
Immune system evolution:
- Primitive organisms (bacteria) began with a small set of defense proteins.
- As organisms grew complex, immune systems accumulated many layers & proteins.
Fate of older mechanisms:
- Some are eliminated; others persist with no clearly assigned function (“evolution forgot about them”).
- Example: large regions of "nonsense" DNA (introns, transposon remnants); still poorly understood.
When writing scientific papers, evolutionary arguments can justify functional speculation.

Bacteriophages (phages): viruses that specifically infect bacteria.
- Phage diversity > bacterial diversity.
- Infection cycles:
- Lytic: cell bursts and dies.
- Lysogenic: phage DNA integrates, lies dormant, sometimes bringing toxin or virulence genes.
Bacteriophages inhabit the human body (gut, skin—"virome") because they prey on resident bacteria.
Bacterial countermeasures:
- Restriction–modification system: enzymes cut un-methylated (foreign) DNA.
- Bacterial DNA is heavily methylated to protect its own restriction sites.
- Later evolutionary layer: CRISPR–Cas (adaptive defense), likened to “restriction enzymes 2.0.”

Concept: use phages as antibacterial drugs (advantage—extreme specificity, active vs. antibiotic-resistant strains).
Challenges
- Need precise identification of pathogen to match phage cocktail.
- Regulatory barriers: not FDA-approved in the United States.
Where available
- Treatments offered in Georgia (Eliava Institute, long-standing phage bank) and in Mexico.
- Environmental sourcing: sewage is a rich hunting ground for new phages.

Cloning workflow summary:
1. Choose plasmid vector.
2. Cut vector with restriction enzymes (molecular scissors).
3. Insert foreign DNA fragment with compatible ends.
4. Ligate, transform, screen.
Bacteriophage-lambda DNA is a common teaching substrate for restriction digests.
The lecturer stresses remembering restriction enzymes as the foundational tool for DNA modification.

Analogy: restriction enzyme = prototype nanodevice (acts, moves, completes a task at nanoscale).
Long-term goal: engineer synthetic nanorobots that can
- Recognize DNA, cut, insert, or replace genes in one integrated machine.
- Perform additional tasks (cargo delivery, repair) inside living cells.
Existing proof-of-concept
- Nature paper (≈5–6 yrs ago) built a DNA-origami “cage” that opens/closes on command (pH-triggered) → dubbed first molecular nanodevice.
Key engineering hurdles
- Power source: electrons are proportionally large; may need alternative energy carriers at the nanoscale.
- Control signals: pH, light, local chemistry, or yet-unknown quantum/ionic flows.

Separation basis: charge and size.
- DNA is negatively charged (phosphate backbone) → migrates to anode (red lead).
- Larger fragments navigate the agarose matrix more slowly.
Loading buffer contents and roles:
- Glycerol: increases sample density → sinks into well.
- Blue tracking dye: visualization while loading/running; indicates front progress.
Agarose gel layout: wells near cathode (black), DNA migrates toward anode (red).
Ladder (molecular weight marker)
- Commercial (Bio-Rad) ladder with defined band sizes.
- Essential for estimating fragment lengths and verifying correct digest.
Today’s laboratory run
1. Lambda DNA + restriction enzymes (specific digest).
2. Two samples from previous day (non-specific Pulmozyme digest) for comparison.
3. Include size ladder in separate lane.
4. Observe band patterns at ~4:15 pm.

Evolutionary perspective aids creative problem-solving; drives biotech innovation.
CRISPR and restriction enzymes inspire synthetic biology, but future nanodevices could transcend natural limits.
Regulation lags behind innovation (e.g., phage therapy legality).
Environmental sampling (“sewage hunting”) raises biosafety and ecological questions.

Fragment formula already listed.
No other explicit quantitative data given, but speaker notes “phage diversity much richer than bacterial diversity” (qualitative).

Restriction enzymes = bacterial immunity prototype, indispensable lab tools, conceptual gateway to nanotechnology.
Phages = both ecological partners and therapeutic options.
Gel electrophoresis techniques integrate with restriction digests for DNA analysis.
Continuous evolution in both biology and technology underpins future breakthroughs.